ADSK vs AMGN · P/E 65, rev $3.98B vs P/E 24, rev $10.05B
Autodesk Inc (ADSK) versus Amgen Inc (AMGN) — a side-by-side from cached financials, not a winner call.
Autodesk Inc (ADSK) is a software - application company listed on US.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Latest reported ADSK revenue for 2026-07-31 was $3.98B. Net income was $983.0M. ADSK currently screens at market cap $67.33B and trailing P/E 65.4.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
ADSK currently screens at market cap $67.33B and trailing P/E 65.4. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Not investment advice. Open the ADSK and AMGN stock pages for the full models.
Not investment advice.